These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36719594)
1. Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil. Silva RC; da Rosa MM; Leão HI; Silva EDL; Ferreira NT; Albuquerque APB; Duarte GS; Siqueira AM; Pereira MC; Rêgo MJBM; Pitta MGR J Neurovirol; 2023 Apr; 29(2):180-186. PubMed ID: 36719594 [TBL] [Abstract][Full Text] [Related]
2. Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value. Gao Y; Duan J; Ji H; Lu W Ann Palliat Med; 2021 Mar; 10(3):3371-3378. PubMed ID: 33849122 [TBL] [Abstract][Full Text] [Related]
3. Serial measurement of S100B and NSE in pediatric traumatic brain injury. Park DW; Park SH; Hwang SK Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330 [TBL] [Abstract][Full Text] [Related]
4. Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. Sahin BE; Celikbilek A; Kocak Y; Saltoglu GT; Konar NM; Hizmali L J Neurol Sci; 2022 Aug; 439():120324. PubMed ID: 35752131 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage as Early Predictors at Discharge from an Intensive Care Unit. Kedziora J; Burzynska M; Gozdzik W; Kübler A; Kobylinska K; Adamik B Neurocrit Care; 2021 Jun; 34(3):856-866. PubMed ID: 32978732 [TBL] [Abstract][Full Text] [Related]
6. Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome. Arnason S; Molewijk K; Henningsson AJ; Tjernberg I; Skogman BH Eur J Clin Microbiol Infect Dis; 2022 Jul; 41(7):1051-1057. PubMed ID: 35665437 [TBL] [Abstract][Full Text] [Related]
7. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients. Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury. Park SH; Hwang SK World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306 [TBL] [Abstract][Full Text] [Related]
9. Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist? Zhang P; Tan CW; Chen GH; Ge YJ; Xu J; Xia L; Wang F; Li XY; Kong XY Sleep Med; 2018 Aug; 48():163-171. PubMed ID: 29957487 [TBL] [Abstract][Full Text] [Related]
11. Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy. Kanavaki A; Spengos K; Moraki M; Delaporta P; Kariyannis C; Papassotiriou I; Kattamis A Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244749 [TBL] [Abstract][Full Text] [Related]
12. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Roka A; Kelen D; Halasz J; Beko G; Azzopardi D; Szabo M Acta Paediatr; 2012 Mar; 101(3):319-23. PubMed ID: 21981269 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of the S100B protein and neuron-specific enolase are associated with mortality in critically ill patients. Duda I; Krzych Ł; Jędrzejowska-Szypułka H; Lewin-Kowalik J Acta Biochim Pol; 2017; 64(4):647-652. PubMed ID: 29222857 [TBL] [Abstract][Full Text] [Related]
14. Serum inflammatory and brain injury biomarkers in COVID-19 patients admitted to intensive care unit: A pilot study. Kokkoris S; Stamataki E; Emmanouil G; Psachoulia C; Ntaidou T; Maragouti A; Kanavou A; Malachias S; Christodouli F; Papachatzakis I; Markaki V; Katsaros D; Vasileiadis I; Glynos C; Routsi C eNeurologicalSci; 2022 Dec; 29():100434. PubMed ID: 36348961 [TBL] [Abstract][Full Text] [Related]
15. Brain-Specific Serum Biomarkers Predict Neurological Morbidity in Diagnostically Diverse Pediatric Intensive Care Unit Patients. Au AK; Bell MJ; Fink EL; Aneja RK; Kochanek PM; Clark RSB Neurocrit Care; 2018 Feb; 28(1):26-34. PubMed ID: 28612133 [TBL] [Abstract][Full Text] [Related]
16. COMPARATIVE EVALUATION AND PROGNOSTIC UTILITY OF NEURONAL INJURY BIOMARKERS IN COVID-19 PATIENTS: A PROSPECTIVE STUDY. Vrettou CS; Vassiliou AG; Pratikaki M; Keskinidou C; Tsipilis S; Gallos P; Jahaj E; Orfanos SE; Kotanidou A; Dimopoulou I Shock; 2022 Dec; 58(6):507-513. PubMed ID: 36548642 [TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of Acute Spinal Cord Injury. Du W; Li H; Sun J; Xia Y; Zhu R; Zhang X; Tian R Med Sci Monit; 2018 Jun; 24():4510-4515. PubMed ID: 29959890 [TBL] [Abstract][Full Text] [Related]
19. Serum biochemical markers of central nerve system damage in children with acute elemental mercury intoxicatıon. Yılmaz FM; Yılmaz H; Tutkun E; Uysal S; Carman KB; Dılber C; Ercan M Clin Toxicol (Phila); 2014 Jan; 52(1):32-8. PubMed ID: 24400932 [TBL] [Abstract][Full Text] [Related]
20. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy. Kaciński M; Budziszewska B; Lasoń W; Zając A; Skowronek-Bała B; Leśkiewicz M; Kubik A; Basta-Kaim A Pharmacol Rep; 2012; 64(6):1427-33. PubMed ID: 23406753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]